HB4518, the Cooper Davis and Devin Norring Act, would amend the Controlled Substances Act to create a new reporting regime for electronic communication service providers and remote computing services. If a provider obtains actual knowledge, or in some cases has a reasonable belief, that its service is being used to create, manufacture, distribute, dispense, or possess with intent to distribute fentanyl, methamphetamine, counterfeit substances, or unauthorized prescription pain medications or stimulants, it must report specified information to the Attorney General within 60 days. The bill also allows providers to include additional contextual information, such as account identifiers, IP addresses, timestamps, geographic indicators, and, at the provider’s discretion, the full communication and related digital files.
The bill directs the Attorney General to review reports, investigate where warranted, and may share reports with other federal, state, or local law enforcement agencies. It also imposes preservation obligations tied to submitted reports, requires annual public reporting on the number and disposition of reports, and adds criminal and civil penalties for providers that fail to report or knowingly submit false or incomplete reports. The measure amends the Stored Communications Act to permit disclosure to the Attorney General in connection with these reports and includes a severability clause.
The bill’s practical impact would be to expand federal law enforcement access to information held by online platforms, cloud services, and other digital providers when those services are used in connection with illicit drug activity. It would create new compliance duties for providers, especially around identifying and reporting suspected drug-related content and preserving associated data, while expressly exempting broadband internet access providers and text messaging services acting in those capacities. It also attempts to limit privacy concerns by stating that providers are not required to monitor users, scan communications, or decrypt end-to-end encrypted messages.
The general sentiment reflected by the bill’s sponsorship is strongly supportive of law enforcement efforts to combat fentanyl, methamphetamine, and counterfeit prescription drug trafficking online. The bill is framed as a public-safety measure aimed at reducing the proliferation of dangerous controlled substances and improving investigative leads for prosecutors and police. No committee transcript or vote record was provided, so there is no recorded floor or committee sentiment beyond the bipartisan-looking list of original cosponsors.
Likely points of contention center on privacy, platform liability, and the scope of provider obligations. Critics may focus on whether the bill effectively pressures companies to monitor user activity, the breadth of information that may be reported, the treatment of encrypted services, and the penalties for noncompliance or incomplete reporting. Supporters are likely to emphasize the bill’s privacy carveouts, its prohibition on mandatory monitoring or decryption, and its targeted focus on fentanyl, methamphetamine, and counterfeit prescription drugs.
The bill would add a new Section 521 to the Controlled Substances Act and make conforming amendments to the Stored Communications Act to authorize disclosures to the Attorney General for these reports. It would impose new federal reporting, preservation, and recordkeeping-related obligations on electronic communication service providers and remote computing services, while exempting broadband internet access service and text messaging service providers acting in those roles. It would also create enforcement mechanisms, including criminal and civil penalties, and require annual DOJ reporting to Congress or the public on implementation and outcomes.
The bill appears to have a generally pro-enforcement, anti-opioid-trafficking orientation, with bipartisan sponsorship suggesting broad interest in addressing online drug sales and counterfeit pills. Because no committee discussion or votes were provided, there is no documented opposition or amendment debate in the record supplied. The overall tone of the legislation is preventative and investigative rather than punitive toward users, with an emphasis on combating fentanyl-related harm.
The main likely contention is between public-safety advocates and privacy/civil-liberties concerns. Supporters would favor mandatory reporting of suspected drug trafficking on digital platforms, while opponents may argue that the bill could incentivize over-reporting, create burdens for service providers, and expand government access to user data. Additional concerns may arise over the scope of “actual knowledge” and “reasonable belief,” the inclusion of full communications and metadata, the interaction with encryption, and whether the bill could indirectly pressure platforms to monitor content more aggressively than the text suggests.